HHS Team Heads To England To Analyze Fluvirin Data
This article was originally published in The Pink Sheet Daily
Executive Summary
CBER Director Jesse Goodman will lead team in discussions with the U.K. regulatory agency. HHS Secretary Thompson hopes to secure a partial release of Fluvirin doses following suspension of Chiron’s license to manufacture influenza vaccine for three months.